| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |